On Tuesday, biotech company Genomic Vision announced the appointment of Frédéric Hammel as Chief Operating Officer to strengthen its management team.

In his new role, Frédéric Hammel, a biologist by training, will be responsible for managing all operational aspects of the company, which specializes in the analysis of genome modifications.

With over 25 years' experience in the healthcare sector, he was previously Managing Director of Ethera, a manufacturer of air quality analysis products.

Prior to this, he had been Managing Director of Platine Pharma Services, an analytical services company since acquired by bioMérieux, and of TxCell, a biotech company developing cellular immunotherapies.

Genomic also announced on Tuesday the appointment of a new Human Resources Director, Claire Fleury, with the aim of bolstering its workforce.

Copyright (c) 2023 CercleFinance.com. All rights reserved.